Table 1 Products assessed by skin prick test and basophil activation test
| Drugs (active ingredients) | Contains PEG | Prick test | BAT |
|---|---|---|---|
|
GripaNait® cough syrup (paracetamol, dextromethorphan, doxylamine) |
+ (macrogol 6000) | + | NP |
|
Betadine® solution (iodopovidone) |
+ (laureth-9) | + | NP |
|
Betadine® gel (iodopovidone) |
+ (PEG 400, 4000 and 6000) | + | NP |
|
Romilar® tablets (dextromethorphan) | − | − | − |
|
Dormidina® 25 mg tablets (doxylamine) |
+ (PEG 8000) | + | + |
|
Dormidina® 12.5 mg tablets (doxylamine) |
+ (PEG 400 and 6000) | Weak + | NP |
|
Cariban® tablets (doxylamine, pyridoxine) | − | − | NP |
|
Polaramine® solution (dexchlorpheniramine) | − | − | − |
|
Soñodor® tablets (diphenhydramine) | − | − | − |
|
Atarax® solution (hydroxyzine) | − | − | NP |
|
FLUIDASA® solution (mepyramine) | − | − | − |
|
Cetirizine solution (cetirizine) | − | − | NP |
|
CETIRIZINE tablets (cetirizine) |
+ (macrogol 4000) | + | + |
|
Ebastel® tablets (ebastine) |
+ (macrogol 6000) | + | + |
|
Ebastel® solution (ebastine) |
+ (oxyethylene polymer) | + | + |
|
Bilaxten® tablets (bilastine) | − | − | − |
|
Loratadine tablets (loratadine) | − | − | NP |
|
Movicol® powder (macrogol 3350, sodium chloride, sodium bicarbonate, potassium chloride) |
+ (macrogol 3350) | + | + |
|
PEG 1500 (1% and 10%) |
+ (PEG 1500) | − | NP |
|
PEG 4000 (1%) |
+ (PEG 4000) | + | + |
| ORAL-B® toothpaste |
+ (PEG-6) | − | − |
|
Ziverel® powder (hyaluronic acid, chondroitin sulfate) |
+ (poloxamer 407) | + | + |
|
Polysorbate 80 (1% and 20%) |
+ (polysorbate 80) |
− in 1% + in 20% |
− at 0.002 mg/ml + at 0.02 mg/ml |
|
Citrafleet® powder (sodium picosulfate, magnesium oxide, citric acid) | − | − | − |
| Paracetamol tablets | − | − | − |